LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. on the re-launch of its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone® (buprenorphine and naloxone) sublingual film, in the United States market.

Buprenorphine and Naloxone Sublingual Film is a prescription medicine indicated for treatment of opioid use disorder.

LTS manufactures the Buprenorphine and Naloxone Sublingual Film for Dr. Reddy’s in its production site in West Caldwell, New Jersey, USA.